# Perfuze funding: rounds and investors > Perfuze has raised $27M across 2 rounds since 2019. Investors include Earlybird Venture Capital, SV Health Investors and EQT Life Sciences. Source: https://millionrounds.com/company/perfuze (Millionrounds; every figure on the page links to its filing or article) Ireland · [Growth startup](https://millionrounds.com/companies) # Who invested in *Perfuze* 2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Healthtech Funding summary Updated 26 Oct 2026 **$27M** raised across 2 rounds since 2019, from 2 sources **$3.4M** Seed **$24M** Growth - **Latest round:** Growth, $24M Mar 2025 - **Led by:** Earlybird Venture Capital and SV Health Investors and 2 more - **Step-up i:** 7× - **Investors:** 6 (4 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 2022 2023 2024 2025 **$3.4M** Seed **$24M** Growth - **First round:** Seed, $3.4M - **Biggest round:** $24M - **Between rounds:** 6.1 years ## The rounds - **Mar 2025** Growth **$24M** *5 new* [Earlybird Venture Capital](https://millionrounds.com/fund/earlybird) Lead [SV Health Investors](https://millionrounds.com/fund/sv-health-investors) Lead [EQT Life Sciences](https://millionrounds.com/fund/eqt-life-sciences) Lead [Seroba.](https://millionrounds.com/fund/seroba) Lead [EQT](https://millionrounds.com/fund/eqt) Reported by Seroba Life Sciences - **Jan 2019** Seed **$3.4M** *1 new* Earlybird/ MedFocus Reported by FinSMEs ## Founders and team From Perfuze's own website: 2 founders, 22 on the team. **Wayne Allen** Co-Founder, CEO, Director **Liam Mullins** CTO and Co-founder - **Ibrahim Ali** Vice President of Marketing - **Joe Rotger** Executive Vice President of Sales - **Paul Maguire** Vice President of Operations - **Anne Portwich** Director - **Daniel O' Mahony** Director - **Dara Finneran** Principal R&D Engineer - **Evin Donnelly** R&D Manager - **Hooman Hakami** Independent Chair - **Jack Brady** Senior Design Assurance Engineer - **James Frizzell** R&D Engineer - **Jestene Ahn** Clinical Technology Manager - **John Yianni** Director - **Josephine Forde** Office Manager - **Kieran Connolly** Manufacturing Engineering Manager - **Liz Williams** R&D Engineer - **Mark McDermott** Senior R&D Engineer - **Michael Murrihy** Financial Director - **Miquel Murillo Artigues** R&D Engineer And 4 more on the team. ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Seed** 2019 **Growth** 2025 [Earlybird Venture Capital](https://millionrounds.com/fund/earlybird) L [SV Health Investors](https://millionrounds.com/fund/sv-health-investors) L [EQT Life Sciences](https://millionrounds.com/fund/eqt-life-sciences) L [Seroba.](https://millionrounds.com/fund/seroba) L [EQT](https://millionrounds.com/fund/eqt) Earlybird/ MedFocus ## Everyone who backed them [Earlybird Venture Capital](https://millionrounds.com/fund/earlybird) VC firm **1** round, led 1 [SV Health Investors](https://millionrounds.com/fund/sv-health-investors) VC firm **1** round, led 1 [EQT Life Sciences](https://millionrounds.com/fund/eqt-life-sciences) VC firm **1** round, led 1 [Seroba.](https://millionrounds.com/fund/seroba) VC firm **1** round, led 1 [EQT](https://millionrounds.com/fund/eqt) Private equity **1** round Earlybird/ MedFocus no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=perfuze). ## Also claim to have backed them This firm lists Perfuze as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Seroba Life Sciences](https://millionrounds.com/fund/seroba-life-sciences) VC firm Per its own site ## Quick answers about Perfuze ### Who invested in Perfuze? Perfuze's investors include Earlybird Venture Capital, SV Health Investors, EQT Life Sciences, Seroba. and EQT, and 1 more on record. Earlybird Venture Capital led its latest round. ### How much has Perfuze raised? Perfuze has raised $27M across 2 rounds since 2019. ### When did Perfuze last raise? Perfuze's most recent round was a Growth of $24M in Mar 2025, led by Earlybird Venture Capital. ### What was Perfuze's biggest round? Its most recent round, $24M in Mar 2025, is also its largest on record. ### Who backed Perfuze first? Perfuze's first round on record, in Jan 2019, was backed by Earlybird/ MedFocus. ### What stage is Perfuze at? Perfuze's latest named round is a Growth, in Mar 2025. ### Where is Perfuze based? Perfuze is based in Ireland. ### Who led Perfuze's rounds? Earlybird Venture Capital led the Growth in 2025. ## Companies like Perfuze In the same sector, and raised in the last eighteen months. [**Neurent Medical** $29M · Sept 2026](https://millionrounds.com/company/neurent-medical)[**Neurobell** $7.6M · Jun 2026](https://millionrounds.com/company/neurobell)[**CroíValve** $41M · Jun 2026](https://millionrounds.com/company/croivalve)[**Aerska** $49M · May 2026](https://millionrounds.com/company/aerska)[**Bluedrop Medical** $13M · Feb 2026](https://millionrounds.com/company/bluedrop-medical)[**CrannMed** $15M · Feb 2026](https://millionrounds.com/company/crannmed) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app